Dr. Handgretinger's main research interests are cellular immunotherapeutic approaches to the treatment of children and adults with various forms of cancer. Advances in Cell and Gene Therapy is an international journal publishing original, high-quality, peer-reviewed articles which cover basic and clinical research relating to advances in cell, gene, and immune therapies, and their use in the treatment of nonmalignant and neoplastic hematological diseases, as well as son non-hematological diseases. PHAGE: Therapy, Applications, and Research is the only peer-reviewed journal dedicated to fundamental bacteriophage research and its applications in medicine, agriculture, aquaculture, veterinary applications, animal production, food safety, and food production. The Journal Impact measures the average number of citations received in a particular year (2019) by papers published in the journal during the two preceding years (2017-2018). The Journal Impact Quartile of Advances in Cell and Gene Therapy is still under caculation.The Journal Impact of an academic journal is a scientometric Metric that reflects the yearly average number of citations that recent articles published in a given journal received. Working off-campus? Each year research scientists have noticed a rise in the number of congresses being held in this field. The topics the journal covers include hematopoietic cell transplants and cell, gene and immune therapies in children and adults with a wide range of disorders, including cancers, genetic and immune diseases. The cover image © Atara Biotherapeutics, Inc. is based on the Original Article, Towards “off-the-shelf” allogeneic CAR T cells by Blake Aftab et al., The cover image is based on the Invited Review. Kuartil Faktor Dampak Advances in Cell and Gene Therapy masih dalam perhitungan.Faktor dampak atau faktor pengaruh atau faktor dampak jurnal dari suatu jurnal akademik adalah ukuran yang mencerminkan jumlah rata-rata sitiran (sitasi) tahunan untuk artikel terbaru yang dipublikasikan di jurnal tersebut. All articles include a section or feature detailing the current and future clinical implications of the research. The goal of Advances in Cell and Gene Therapy is to become a source for easily comprehendible, unbiased, accurate and up-to-date studies and reviews about the field, along with provocative commentaries from internationally renowned experts. Faktor Dampak 2019 dari Advances in Cell and Gene Therapy masih dalam perhitungan. Dr. Abutalib is the Founding Editor of Advances in Cell and Gene Therapy. Over the past decade, gene therapy has enabled curative outcomes in previously untreatable genetic diseases such as X-linked severe combined immunodeficiency. ISSN: 1757-6512. Stem Cell Research & Therapy Impact Factor, IF, number of article, detailed information and journal factor. The Journal has an extensive, internationally renowned Editorial team, consisting of experts within the field of cell and gene therapy who work alongside the Editors-in-Chief. If you do not receive an email within 10 minutes, your email address may not be registered, After his fellowship, he became the director of the stem cell laboratory at the same hospital, where he was involved in the development and clinical applications of new graft-engineering techniques. Working off-campus? The impact factor of Molecular Therapy, ASGCT’s first and primary journal, rose 19.9 percent to 8.402 and remains the top journal in the field. Please visit the journal's Aims & Scope and Author Guidelines pages for further information. The Journal Impact 2019-2020 of Advances in Cell and Gene Therapy is still under caculation. Dr. Rupert Handgretinger earned his medical degree from the University of Tübingen, Germany. The journal will be a robust, engaging tool to aid vital activities in daily work settings - each article will include a clinical/scientific implications section that indicates the practical relevance of the research to clinicians in the field. The Journal of Genetic Syndromes & Gene Therapy is an academic journal – hosted by OMICS International – a pioneer in open access publishing–and is listed among the top 10 journals on Fungus. The Journal of Genetic Syndromes & Gene Therapy is an academic journal – hosted by OMICS International – a pioneer in open access publishing–and is listed among the top 10 journals on Fungus. Dr. Abutalib has co-edited ten Hematology and Bone Marrow Transplant books over a short span of 4 years and has published in a number of cancer magazines, journal, and textbooks. Learn about our remote access options, Edited By: Syed A. Abutalib & Rupert Handgretinger. and you may need to create a new Wiley Online Library account. Advances in Cell and Gene Therapy is an international journal publishing original, high-quality, peer-reviewed articles which cover basic and clinical research relating to advances in cell, gene, and immune therapies and their use in the treatment of nonmalignant and neoplastic hematological diseases, as well as some non-hematological diseases. The latest impact factor scores for the Molecular Therapy family of journals, the official journals of the American Society of Gene & Cell Therapy (ASGCT), rose by a collective average of 27.9 percent when released on Thursday, June 20. Enter your email address below and we will send you your username, If the address matches an existing account you will receive an email with instructions to retrieve your username. If you do not receive an email within 10 minutes, your email address may not be registered, OMICS International – a pioneer in organizing international conferences 6th Cell and Stem Cells Research Congrssene Therapy to be held during Feb 29- march 2, 2016 at Philadephia, USA. Given the rapid positive advances in the field of cell and gene therapies and the explosive growth of immunotherapy for nonmalignant and neoplastic disorders, the journal's content will be useful for readers worldwide. Dr. Syed A. Abutalib earned his medical degree from Dow Medical College in Karachi, Pakistan. In 2000, he was appointed the Director of the Division of Stem Cell Transplantation at the St. Jude Children's Research Hospital in Memphis, USA, where he also served as the director of the stem cell laboratory, and as a full faculty member and Professor of Pediatrics at the University of Tennessee, Memphis. Dr. Handgretinger has published and co-published over 400 articles in the field of pediatric hematology/oncology and allogeneic stem cell transplantation. The Journal of Cell Science & Therapy (JCEST) is an Open access, peer-reviewed, academic journal with an Impact Factor of 3.27 and Index Copernicus Value of 5.12. Advances in Cell and Gene Therapy is an international journal publishing original, high-quality, peer-reviewed articles which cover basic and clinical research relating to advances in cell, gene, and immune therapies and their use in the treatment of nonmalignant and neoplastic hematological diseases, as well as some non-hematological diseases. Dr. Abutalib continues to collaborate with other experts worldwide in the area of hematology/oncology and transplantation to explore and develop innovative ideas and breakthroughs in Medical Education with a primary focus on improvement of patient care. Gene therapy development for hemophilia B preceded that of hemophilia A, as the factor IX gene was smaller in size and easier to fit into AAV vectors than was the factor VIII gene . In 2010, Dr. Handgretinger was appointed the Medical Director of the Children's University Hospital in Tübingen. Molecular Therapy is the monthly publication of the American Society of Gene Therapy (ASGT). Cytotherapy, the official journal of the International Society for Cell & Gene Therapy (ISCT®), publishes novel and innovative results from high quality scientific and clinical studies in the fields of cell and gene therapy. For the full list, please visit the Editorial Board page. The following is a list of the most cited articles based on citations published in the last three years, according to CrossRef. News. PHAGE: Therapy, Applications, and Research is the only peer-reviewed journal dedicated to fundamental bacteriophage research and its applications in medicine, agriculture, aquaculture, veterinary applications, animal production, food safety, and food production. Please check your email for instructions on resetting your password. Advances in Cell and Gene Therapy is an international journal publishing original, high-quality, peer reviewed articles which cover basic and clinical research relating to advances in cell, gene, and immune therapies, and their use in the treatment of nonmalignant and neoplastic hematological diseases, as well as some non-hematological diseases.